JP2001517215A - 生理活性物質の生産におけるタンパク質に代わる又は特定免疫制御用の選択されたｒｎａの使用 - Google Patents

生理活性物質の生産におけるタンパク質に代わる又は特定免疫制御用の選択されたｒｎａの使用

Info

Publication number
JP2001517215A
JP2001517215A JP53753298A JP53753298A JP2001517215A JP 2001517215 A JP2001517215 A JP 2001517215A JP 53753298 A JP53753298 A JP 53753298A JP 53753298 A JP53753298 A JP 53753298A JP 2001517215 A JP2001517215 A JP 2001517215A
Authority
JP
Japan
Prior art keywords
rna
proteins
substance
synthesis
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP53753298A
Other languages
English (en)
Japanese (ja)
Inventor
ステュンゼナス，ヴィルマンタス
Original Assignee
ステュンゼナス，ヴィルマンタス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ステュンゼナス，ヴィルマンタス filed Critical ステュンゼナス，ヴィルマンタス
Publication of JP2001517215A publication Critical patent/JP2001517215A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP53753298A 1997-02-28 1998-02-24 生理活性物質の生産におけるタンパク質に代わる又は特定免疫制御用の選択されたｒｎａの使用 Pending JP2001517215A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LT97-027A LT4475B (lt) 1997-02-28 1997-02-28 Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse
LT97-027 1997-02-28
PCT/LT1998/000001 WO1998037900A1 (en) 1997-02-28 1998-02-24 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control

Publications (1)

Publication Number Publication Date
JP2001517215A true JP2001517215A (ja) 2001-10-02

Family

ID=19721814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53753298A Pending JP2001517215A (ja) 1997-02-28 1998-02-24 生理活性物質の生産におけるタンパク質に代わる又は特定免疫制御用の選択されたｒｎａの使用

Country Status (5)

Country Link
JP (1) JP2001517215A (lt)
DE (1) DE19882018T1 (lt)
GB (1) GB2337462A (lt)
LT (1) LT4475B (lt)
WO (1) WO1998037900A1 (lt)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824411A1 (de) * 1978-06-03 1979-12-13 Boehringer Sohn Ingelheim Antiviral wirksame t-rna-praeparate
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2598619A1 (fr) * 1986-05-16 1987-11-20 Mafitra Management Services In Medicament antiviral a base d'acide nucleique modifie, et son procede de preparation
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
CA2126686A1 (en) * 1991-12-24 1993-07-08 Mark D. Howell Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
CA2110946A1 (en) 1992-12-09 1994-06-10 Elazar Rabbani Induction of immunocompatibility by nucleic acid
IL112873A (en) * 1994-03-08 2005-03-20 Wyeth Corp Rapamycin-fkbp12 binding proteins, their isolation and their use

Also Published As

Publication number Publication date
LT4475B (lt) 1999-02-25
LT97027A (lt) 1998-09-25
DE19882018T1 (de) 2000-01-13
GB9918974D0 (en) 1999-10-13
GB2337462A (en) 1999-11-24
WO1998037900A1 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
US5601818A (en) Cancer therapy utilizing malignant cells expressing HSV-TK
DE69435096T2 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DE69834494T2 (de) Vorrichtung zur induktion einer ctl-antwort
CA2425745C (en) Expression of exogenous polynucleotide sequences in a vertebrate
DE69923840T2 (de) Transfer von mRNAs unter Verwendung von polykationischen Verbindungen
Schmidt-Wolf et al. Cytokines and gene therapy
WO1997026910A2 (de) Tumorimpfstoff für die immuntherapie von malignen tumoren
US8802113B2 (en) Extracellular matrix cancer vaccine adjuvant
WO2006008154A1 (de) mRNA-GEMISCH ZUR VAKZINIERUNG GEGEN TUMORERKRANKUNGEN
EP2109667B1 (en) Extracellular matrix cancer vaccine adjuvant
US5670148A (en) Combined cellular and immunosuppressive therapies
US4931275A (en) Anti-tumor vaccines and their preparation
DE69627527T2 (de) Allogene parakrine cytokine tumor impfstoffe
JPH10505339A (ja) 腫瘍疾患の治療のための生ワクチン
EP0693120B1 (de) Tumorizide t-lymphozyten
JP2001504487A (ja) インスリン様生長因子１型受容体（ｉｇｆ―１ｒ）アンチセンスオリゴヌクレオチド処理乳癌細胞組成物
JP2004026802A (ja) 人間あるいは動物体内の癌あるいは腫瘍を治療する薬物を製造する方法
JP2001517215A (ja) 生理活性物質の生産におけるタンパク質に代わる又は特定免疫制御用の選択されたｒｎａの使用
DE3236298C2 (lt)
RU2236868C1 (ru) Полиакриламидная капсула, содержащая антигенный материал, способ формирования иммунного ответа и способ иммунотерапии и иммунопрофилактики метастазирования раковых заболеваний
EP0615758A1 (en) Anti-tumor vaccines
Rang et al. Therapeutic modalities
TW442294B (en) Device and process for manufacturing a device for implanting tumor cells for the prevention and treatment of cancer
JPH1067681A (ja) 癌ワクチン及びその製造法
Aventis MEDICAL ADVANCES AND ANIMAL RESEARCH THE CoNTRIbuTIoN of ANIMAL SCIENCE To THE MEDICAL REVoLuTIoN: SoME CASE HISToRIES